This grant proposal aims to identify the peptides that mediate T cell help for dsDNA-specific B lymphocytes in lupus. Systemic lupus erythematosus (SLE) is a disease of unknown etiology. Female (NZB x NZW) F1 (abbreviated B/W) mice recapitulate most of the salient characteristics of human lupus patients. Among these characteristics are serum antibodies to dsDNA, which are specific for the clinical diagnosis in a majority of SLE patients, as well as in all older B/W mice. An important question, therefore, is what drives production of high-affinity anti-dsDNA antibody? In the B/W mouse, the generation of high-affinity anti-dsDNA antibodies of IgG class is absolutely T-helper- cell dependent. dsDNA by itself is not an antigen in either normal or B/W mice, and DNA is not bound and presented by MHC molecules to T helper cells. The prevailing hypothesis is that DNA-protein complexes such as nucleosomes mediate the generation of high-affinity IgG antibodies. But the identity of the physiological B cell antigen is unknown. Specifically, there are no peptides known that are presented by dsDNA-specific B cells from any lupus-prone mouse model. As a result, it is not known how T cells help induce high-affinity anti-dsDNA antibodies. To reduce the complexity of the autoimmune response, we will make use of a classic lupus mouse model that has been modified by transgenesis in a conceptually simple way. It yields a quasimonoclonal auto- immune response to (only) dsDNA, while leaving the kinetics of the response intact. Unlike the germinal center B cells in old wild-type B/W mice, with various antigenic specificities, the majority of the B cells of the old transgenic mice have identical and monoclonal dsDNA specificity with high affinity. We will sort the germinal center B cells, and elute and identify th peptides bound to their class II molecules. We will then test these peptides for their ability to stimulate T cells of the B/W mice and for their function in the production of anti-dsDNA antibody. This will indicate which antigen is internalized by the immunoglobulin receptor of B cells with high affinity to dsDNA.

Public Health Relevance

Peptides presented by DNA-specific B lymphocytes in lupus Antibodies to double-stranded DNA are specific for the clinical diagnosis in a majority of lupus patients, as well as in lupus-prone mice. To understand the onset of lupus, we propose to identify the molecules that are bound to B lymphocytes and that help trigger these antibodies.

National Institute of Health (NIH)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Exploratory/Developmental Grants (R21)
Project #
Application #
Study Section
Cellular and Molecular Immunology - B Study Section (CMIB)
Program Officer
Mancini, Marie
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of California San Francisco
Schools of Medicine
San Francisco
United States
Zip Code